(TRNS) Transcat - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8935291075

TRNS: Calibration, Laboratory, Instruments, Services, Test, Measurement

Transcat Inc, a company listed on the NASDAQ under the ticker TRNS, is a provider of calibration and laboratory instrument services, operating across the United States, Canada, and international markets. The company's operations are divided into two primary segments: Service and Distribution. The Service segment is focused on delivering a range of services including calibration, repair, inspection, and preventative maintenance, all of which are critical for ensuring the accuracy and reliability of instruments used in various industries. Additionally, this segment offers consulting services and analytical qualification, further emphasizing the company's commitment to comprehensive support. A key component of the Service segment is CalTrak, a proprietary system designed to manage the workflow of calibration service centers and customer assets efficiently. Furthermore, the Compliance, Control and Cost portal provides customers with a secure, web-based platform for asset management and the storage of calibration and service records, enhancing transparency and accessibility.

The Distribution segment of Transcat Inc is dedicated to the sale and rental of test, measurement, and control instruments, catering to the diverse needs of customers in terms of test and measurement instrumentation. This segment also offers a variety of value-added services, including the calibration and certification of purchased equipment, equipment rental options, the sale of used equipment, and equipment kitting services. These services are marketed and sold through multiple channels, including the company's website, digital and print advertising, proactive outbound sales efforts, and an inbound call center. This multi-channel approach enables Transcat Inc to reach a broad customer base and provide convenient access to its products and services. The company's customer portfolio spans highly regulated industries, with a significant focus on life sciences, including pharmaceutical, biotechnology, and medical device companies, as well as aerospace and defense, industrial manufacturing, energy and utilities, and other sectors where precision and compliance are paramount.

With its incorporation dating back to 1964, Transcat Inc has established itself as a veteran player in the industry, with its headquarters located in Rochester, New York. The company's website, https://www.transcat.com, serves as a central hub for information and services, offering insights into its operations, products, and commitment to quality and customer satisfaction. As a publicly traded company, Transcat Inc's common stock is listed under the ISIN US8935291075, and it is classified under the GICS Sub Industry as a Trading Company & Distributor, reflecting its role in the supply chain of critical instruments and services for various industries.

Additional Sources for TRNS Stock

TRNS Stock Overview

Market Cap in USD 985m
Sector Industrials
Industry Industrial Distribution
GiC Sub-Industry Trading Companies & Distributors
IPO / Inception 1990-03-27

TRNS Stock Ratings

Growth 5y 78.1%
Fundamental 35.9%
Dividend -
Rel. Strength Industry -85.1
Analysts 4.4/5
Fair Price Momentum 113.76 USD
Fair Price DCF 47.13 USD

TRNS Dividends

No Dividends Paid

TRNS Growth Ratios

Growth Correlation 3m -23.1%
Growth Correlation 12m -3%
Growth Correlation 5y 93.7%
CAGR 5y 26.38%
CAGR/Mean DD 5y 1.93
Sharpe Ratio 12m 0.21
Alpha -15.46
Beta 0.68
Volatility 45.38%
Current Volume 114.2k
Average Volume 20d 75.3k
What is the price of TRNS stocks?
As of January 22, 2025, the stock is trading at USD 104.58 with a total of 114,186 shares traded.
Over the past week, the price has changed by -1.13%, over one month by -0.57%, over three months by -21.19% and over the past year by +3.85%.
Is Transcat a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Transcat (NASDAQ:TRNS) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 35.91 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRNS as of January 2025 is 113.76. This means that TRNS is currently overvalued and has a potential downside of 8.78%.
Is TRNS a buy, sell or hold?
Transcat has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy TRNS.
  • Strong Buy: 3
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for TRNS stock price target?
According to ValueRays Forecast Model, TRNS Transcat will be worth about 125.2 in January 2026. The stock is currently trading at 104.58. This means that the stock has a potential upside of +19.67%.
Issuer Forecast Upside
Wallstreet Target Price 121.2 15.9%
Analysts Target Price 121.2 15.9%
ValueRay Target Price 125.2 19.7%